Infants born to mothers under phenobarbital treatment: correlation between serum levels and clinical features of neonates

Serum levels of phenobarbital remained in the therapeutic range for both mothers and infants, and reduced gradually in infants. However, some infants displayed symptoms related to phenobarbital. As such, a clinical pharmacological surveillance protocol is necessary.